How much dividend does Pharnext pay?
Over the past 12 months, Pharnext paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharnext is expected to pay a dividend of 0 EUR.
Pharnext Dividend 2024
Pharnext Dividend
0 EUR
Pharnext Dividend yield
Ticker
ALPHA.PA
ISIN
FR0011191287
WKN
A2AM02
How much dividend does Pharnext 2024 pay?
According to the latest status from November 2024, Pharnext paid a total of 0 EUR per share in dividends within the last 12 months. With the current Pharnext price of 0 EUR, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Pharnext Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the Pharnext Dividend Safe?
Pharnext has been increasing the dividend for 0 years.
Over the past 10 years, Pharnext has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Pharnext's Dividend Distributions
Pharnext’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Pharnext's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Pharnext's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Pharnext’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Pharnext Aktienanalyse
What does Pharnext do?
Pharnext SA is a French biopharmaceutical company specializing in the development of innovative therapies for neurological diseases. The company was founded in 2007 by Professor Daniel Cohen and is headquartered in Paris. Pharnext's focus is on identifying synergistic effects of existing drugs to develop novel and effective therapies. The business model of Pharnext is based on the concept of "pleotherapy," which involves using multiple drugs simultaneously. These drug combinations are optimized to act synergistically and achieve better treatment outcomes than individual drugs alone. This allows Pharnext to achieve higher efficacy and lower toxicity. Pharnext operates in two main areas: developing therapies for neurological diseases such as Alzheimer's, Parkinson's, MND (Motoneuron Disease), Charcot-Marie-Tooth (CMT), and other rare diseases, and providing analysis and diagnostic tools for rare diseases. A significant product of Pharnext is PXT3003, a proprietary combination of three drugs for the treatment of Charcot-Marie-Tooth (CMT). PXT3003 is in Phase III clinical development and has the potential to be a groundbreaking therapy for one of the most common hereditary neuropathies worldwide. The company is also developing other products, such as PXT864 for Alzheimer's, PXT002331 for Parkinson's, and PXT002331 for MND, all of which are in clinical development. Pharnext also collaborates with other biotech and pharmaceutical companies to leverage synergies and advance the development of its therapies. For example, the company collaborates with Ipsen for the development of PXT3003 and with Galapagos for the development of drug candidates against inflammatory diseases. Overall, Pharnext aims to take a leading role in the development of therapies for neurological diseases. The company focuses on innovative approaches to maximize the potential of drug combinations and develop novel and effective therapies. Pharnext is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Pharnext stock
What is the dividend yield of Pharnext?
The current dividend yield of Pharnext is .
When does Pharnext pay dividends?
Pharnext pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Pharnext?
Pharnext paid dividends every year for the past 0 years.
What is the dividend of Pharnext?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Pharnext located?
Pharnext is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pharnext kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pharnext from 11/4/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.
When did Pharnext pay the last dividend?
The last dividend was paid out on 11/4/2024.
What was the dividend of Pharnext in the year 2023?
In the year 2023, Pharnext distributed 0 EUR as dividends.
In which currency does Pharnext pay out the dividend?
The dividends of Pharnext are distributed in EUR.
Andere Kennzahlen von Pharnext
Our stock analysis for Pharnext Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharnext Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
